The Gut-Immune System: Key Insights Revealed with Hormone

Explore how the gut-immune system and hormones impact your body’s defense mechanisms and overall health in our latest blog post.

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through how the gut microbiome, immune system, and hormonal networks interact to shape health outcomes—especially digestion, mood, thyroid function, and estrogen metabolism. I explain the physiology of short-chain fatty acids (SCFAs), intestinal permeability, the estrobolome, and bile acid signaling; why dysbiosis drives insulin resistance, autoimmunity, and mood changes; and how integrative chiropractic care fits in by regulating autonomic tone, motility, rib cage and diaphragmatic mechanics, and lymphatic flow. I detail actionable protocols for microbiome restoration, barrier repair, estrogen detoxification pathways (2-hydroxy, 4-hydroxy, 16-hydroxy; methylation; glucuronidation), and thyroid support with vitamin D, vitamin K2, magnesium, iodine, and selenium—backed by modern research, including multi-omics, randomized trials, and mechanistic studies. I also share clinical observations from my practice and professional platforms to help you move from symptomatic management to durable, whole-person health.

Healthy Gut Barrier and Microbiome: The Physiological Hub

Over years of practice across chiropractic, advanced nursing, and functional medicine, I learned that the gut is the primary interface for nutrient signaling, immune education, and neuroendocrine modulation. When we restore the gut ecosystem and epithelial integrity, downstream systems often normalize in ways that drugs alone rarely achieve.

• What a healthy barrier does

• • A single layer of epithelial cells linked by tight junctions (claudins, occludins) selectively permits nutrients while keeping antigens and lipopolysaccharide (LPS) out of circulation (Fasano, 2012).
  • The gut-associated lymphoid tissue (GALT)—about 70% of immune tissue—samples luminal content to train immune tolerance (Belkaid & Hand, 2014).
  • Beneficial microbes convert fibers to SCFAs—including butyrate, propionate, and acetate—which fuel colonocytes, enhance barrier integrity, and modulate inflammation via G-protein-coupled receptors and HDAC inhibition (Koh et al., 2016).

• Why permeability matters

• • Disrupted tight junctions increase intestinal permeability (“leaky gut”), allowing LPS and food antigens into the lamina propria, triggering cytokines that impair insulin signaling, alter thyroid conversion (T4 to T3), and dysregulate sex hormones (Camilleri et al., 2019; Cani et al., 2008; Furlanetto et al., 2006).

• Microbial signaling beyond digestion

• • Gut microbes modify bile acids that activate FXR and TGR5, influencing glucose homeostasis, lipid metabolism, and energy expenditure (Jia et al., 2018).
  • The tryptophan–kynurenine pathway shifts under dysbiosis, reducing serotonin availability and affecting mood and sleep (Agus et al., 2018).

Physiological Underpinnings Explained

The gut’s bioactive outputs are chemical messengers. Butyrate increases mucin production, fuels colonocytes, tightens junctions, and dampens NF-? B signaling; propionate and acetate feed hepatic gluconeogenesis and peripheral energy metabolism. When Proteobacteria expand, LPS levels rise, binding to TLR4 on immune cells and driving metabolic endotoxemia, Th17 skewing, and insulin resistance through serine phosphorylation of insulin receptor substrates (Cani et al., 2008). Microbial ?-glucuronidase can deconjugate estrogens, sending them back into circulation if motility is sluggish—thereby intensifying symptoms such as breast tenderness and heavy cycles (Plottel & Blaser, 2011).

Why Does Dysbiosis Show Up as Whole-Body Symptoms?

In my practice, patients who eat “clean,” exercise, and supplement can still struggle with fatigue, acne, eczema, postprandial crashes, and mood swings. We often identify reduced butyrate-producing taxa (Faecalibacterium, Roseburia), elevated LPS load, and altered microbial enzymes such as ?-glucuronidase. Once we restore microbial diversity and barrier integrity, skin clears, energy returns, and glycemic variability stabilizes (Koh et al., 2016; Cani et al., 2008). I document these patterns and case progressions at my professional platforms: https://chiropracticscientist.com/ and https://www.linkedin.com/in/dralexjimenez/.

Seasonal Immune Dips and Mood: The Holiday-to-New-Year Pattern

Between 2025-12-01 and 2025-12-31, alcohol, sugar, and processed foods often increase while stress and sleep decrease. By early January 2026, many patients report respiratory infections, acne/eczema flares, and seasonal depressive symptoms.

• Mechanistic drivers

• • Excess sugar and alcohol favor pro-inflammatory taxa and loosen tight junctions via zonulin signaling (Voigt et al., 2014).
  • Stress elevates cortisol and reduces secretory IgA, weakening mucosal defenses (Mayer et al., 2015).
  • Circadian disruption alters epithelial clock gene expression and melatonin levels, thereby disrupting barrier rhythms and microbiota cycling (Voigt et al., 2014).

When we rehabilitate the gut in January—fiber diversity, fermented foods, circadian regularity, and stress downregulation—mood improves alongside fewer infections, affirming the gut–immune–brain triad.

Dysbiosis and Clinical Patterns: How to Recognize and Test

• Common manifestations

• • Digestive: bloating, gas, constipation/diarrhea, FODMAP intolerance
  • Metabolic: insulin resistance, postprandial fatigue, weight gain
  • Immune: allergies, recurrent infections, autoimmune markers (e.g., thyroid)
  • Dermatologic: acne, eczema, rosacea
  • Neuropsychiatric: anxiety, low mood, brain fog, sleep disruption

• Targeted assessment

• • History: symptom onset around holidays, antibiotics, food triggers, and alcohol
  • Physical: abdominal tenderness, distension, thoracolumbar mechanics
  • Testing: comprehensive stool analysis (diversity, SCFAs, pathobionts, ?-glucuronidase), breath testing for SIBO where indicated, hs-CRP, fasting insulin/HOMA-IR, selected permeability markers, nutrient status (vitamin D, B12, folate, ferritin, magnesium, selenium) (Hill et al., 2014; Asnicar et al., 2021; Wastyk et al., 2021)

Why Focus on Function

Functional capacity—SCFA output, bile acid signaling, barrier integrity—matters more than the presence or absence of a single pathogen. Modern microbiome methods and multi-omics emphasize host–microbe signaling over simplistic “bug hunting.”

Modulating Women’s Hormones- Video

Integrative Chiropractic Care: Autonomic Balance, Motility, and Lymphatic Flow

Chiropractic fits naturally into gut-centered care because the autonomic nervous system and biomechanics shape motility, secretion, and immune tone.

• How chiropractic helps

• • Autonomic regulation: Precise adjustments and soft-tissue care reduce sympathetic overdrive and enhance vagal tone, thereby improving gastric motility, pancreatic secretion, and anti-inflammatory pathways (Breit et al., 2018; Porges, 2011).
  • Viscerosomatic reflexes: Segmental facilitation around T5–T9 (stomach/liver) and T10–L2 (intestine/colon) can perpetuate gut distress; mobilization reduces nociceptive input and systemic sympathetic drive.
  • Diaphragmatic mechanics: Rib cage mobility and diaphragmatic excursion improve intra-abdominal pressure and lymphatic flow, thereby aiding mucosal immune clearance.
  • Pelvis and sacrum: Lumbosacral mechanics influence pelvic floor coordination and colonic transit, lowering constipation patterns and bloating.

• Clinical observations

• • When I combine targeted adjustments with breathwork and movement medicine, patients report improved bowel regularity and diminished abdominal distension within weeks. These changes align with improved HRV, steadier sleep, and lower perceived stress—conditions that allow microbial therapies and nutrition to work better. I share ongoing clinical insights at https://chiropracticscientist.com/ and https://www.linkedin.com/in/dralexjimenez/.

Nutrition to Feed Microbes and Protect the Mucosa

Food is the primary lever for microbiome diversity and barrier strength.

• What to emphasize

• • Fiber diversity: Aim for 30+ plant types per week to broaden microbial networks and SCFA production (Asnicar et al., 2021).
  • Resistant starches: Cook-and-cool potatoes, green bananas—boost butyrate and improve glucose homeostasis.
  • Polyphenols: Berries, olives, green tea, cacao—prebiotic modulators and antioxidants.
  • Fermented foods: Kefir, sauerkraut, kimchi—increase microbiome diversity and reduce inflammatory markers (Wastyk et al., 2021).
  • Omega-3 fats: EPA/DHA reduce NF-? B signaling and support membrane fluidity (Calder, 2017).
  • Protein timing and quality: Adequate intake matched to digestive capacity; consider enzymes for hypochlorhydria or bile sluggishness.

Why These Choices Work?

Fibers and polyphenols reshape microbial communities, enhance butyrate, strengthen tight junctions, and rebalance bile acid signaling through FXR/TGR5. Omega-3s have an anti-inflammatory tone, supporting insulin sensitivity and mood.

Precision Supplementation: Tools Matched to Mechanisms

Supplements should target specific deficits: barrier integrity, microbial balance, motility, bile flow, and metabolic signaling.

• Probiotics and prebiotics

• • Multi-strain Lactobacillus and Bifidobacterium support barrier function and immune modulation; spore-based options can improve resilience and reduce bloating in certain patterns (Hill et al., 2014).
  • Inulin, FOS, GOS, and PHGG feed beneficial taxa and increase SCFAs; titrate to tolerance.

• Barrier and motility support

• • L-glutamine and zinc carnosine fortify tight junctions and epithelial repair.
  • Butyrate donors (tributyrin, sodium butyrate) nourish colonocytes and reduce inflammation (Koh et al., 2016).
  • Digestive enzymes and bile support improve nutrient assimilation and reduce upstream fermentation.

• Metabolic and antimicrobial modulation

• • Berberine activates AMPK to regulate glucose and selectively modulates dysbiosis (Zhang et al., 2020).
  • Vitamin D, magnesium, and selenium optimize immune and thyroid cofactor status (van Schoor & Lips, 2017; Deng et al., 2013; Kohrle, 2005).

Estrogen Metabolism and the Estrobolome: Pathways and Clearance

Women’s health highlights how gut, liver, and hormones converge. I routinely map estrogen detoxification through phase 1 hydroxylation (2-hydroxy, 4-hydroxy, 16-hydroxy), phase 2 methylation (COMT), glucuronidation, and sulfation, and ensure elimination via daily bowel movements.

• Pathway basics

• • 2-hydroxy metabolites are generally safer and less genotoxic.
  • 4-hydroxy can form quinones that generate DNA adducts if methylation is impaired.
  • 16-hydroxy metabolites are more proliferative and are often linked to breast tenderness and heavy cycles (Cavalieri & Rogan, 2011; Zuberi et al., 2021).

• Methylation and conjugation

• • MTHFR, folate, B12, B6, choline, and betaine support COMT methylation of catechol estrogens, preventing reactive intermediates (Weinshilboum & Sladek, 1980).
  • Glucuronidation packages estrogens for excretion; gut ?-glucuronidase can deconjugate them, enabling enterohepatic recirculation if stool lingers 48–72 hours (Goldin & Gorbach, 1984; Sui et al., 2021).

• Practical nutrition

• • Cruciferous vegetables provide I3C and DIM, favoring 2-hydroxy metabolism and supporting receptor balance (Reed et al., 2006).
  • Allium family supports glutathione and phase 2 enzymes.
  • Fiber binds conjugated estrogens and fosters SCFAs.

• My clinical protocol

• • Promote daily, complete bowel movements with fiber, hydration, and movement.
  • Reduce dysbiosis and ?-glucuronidase-producing bacteria; consider calcium D-glucarate when stool analyses show an elevation.
  • Sequence care: calm the nervous system, repair the gut barrier, restore motility, balance microbes, then refine hormones. When patients follow this order, PMS and PMDD symptoms often improve within 4–8 weeks.

DIM, Sulforaphane, and Targeted Nutraceuticals for HRT Support

For patients on hormone replacement therapy (HRT) or with estrogen-dominant symptoms, I often deploy DIM, sulforaphane, methylated B vitamins, CoQ10, fenugreek, and shilajit in a personalized stack.

• • DIM

• • Encourages CYP1A1-mediated shift toward 2-hydroxyestrone, away from reactive 4-hydroxy and proliferative 16?-hydroxy routes; modulates AhR and phase II enzymes (Bradlow et al., 1998; Safe et al., 2013; Li et al., 2013).
  • Dosing: Women 100–300 mg/day (start 150 mg); Men 300–600 mg/day when targeting prostate cellular health; pair with methylated Bs to support COMT.

• Sulforaphane

• • Activates Nrf2, upregulating GST, NQO1, and UGT; inhibits NF-?B and reduces inflammatory cascades relevant to cyclic breast tenderness and pelvic discomfort (Clarke et al., 2011; Pall & Levine, 2015; Zhang et al., 2016).

• Shilajit and free testosterone

• • Late in pellet cycles, total T can remain adequate while free testosterone drops due to SHBG dynamics. Shilajit (250–500 mg/day, standardized) has randomized-trial evidence for increasing total and free T; clinically, it stabilizes free T in the late cycle and reduces pre-replacement “crashes” (Pandit et al., 2015; Corso et al., 2017).
  • I emphasize maintaining free T over pushing total T to minimize side effects (acne, erythrocytosis, mood volatility).

• CoQ10 and fenugreek

• • CoQ10 supports mitochondrial ATP and antioxidant defense; useful in fatigue and metabolic strain (Littarru & Tiano, 2007; Saini, 2011).
  • Fenugreek can assist with glucose and lipid regulation and may modestly influence androgen dynamics, which is valuable in PCOS phenotypes (Basch et al., 2003; Steels et al., 2011).

Thyroid Health, Vitamin D–K2–Magnesium Synergy, and Iodine–Selenium Balance

Thyroid physiology depends on nutrient sufficiency and oxidative control during hormone synthesis.

• Vitamin D must be paired correctly.

• • Take vitamin D with fat for absorption; deficiency is widespread and linked to immune and cardiometabolic risks (van Schoor & Lips, 2017; Scragg, 2018; Heath et al., 2019).
  • Magnesium is a cofactor for vitamin D activation and receptor signaling; vitamin K2 (MK-7) directs calcium to bone and prevents vascular calcification; vitamin A coordinates bone remodeling and mucosal immunity (Deng et al., 2013; Knapen et al., 2015; Schurgers et al., 2008; McCollum et al., 2016).
  • Practical approach: For 25(OH)D < 40 ng/mL, I may start at 10,000 IU/day for 1 month, then 5,000 IU/day, retesting every 8–12 weeks to maintain ~50–60 ng/mL. Add magnesium (200–400 mg/day) and K2 (100–200 mcg/day).

• Iodine–selenium and hydrogen peroxide control

• • Thyroid hormone synthesis uses iodine and thyroid peroxidase, generating H2O2; selenium-dependent enzymes neutralize H2O2, protecting thyroid tissue from oxidative damage (Kohrle, 2005).
  • I pair iodine repletion (often 12.5 mg/day when indicated) with selenium (100–200 mcg/day), plus zinc and antioxidant support, and I correct gut absorption barriers to ensure benefits.

• Hashimoto’s and gut interplay

• • Dysbiosis and leaky gut amplify cytokines and molecular mimicry, increasing autoantibody formation (Virili et al., 2019).
  • Clinical strategy: restore barrier integrity, optimize micronutrients, stage iodine carefully with selenium, and use integrative chiropractic care to normalize autonomic tone, improve sleep, and support GI motility. In my practice, symptom stabilization and improved HRV often accompany better bowel habits and nutrient absorption.

A Practical, Stepwise Protocol

I use a sequenced plan to avoid flares and maximize tolerance.

• Phase 1: Foundation and assessment

• • Map symptoms, triggers, and stress-sleep patterns; order targeted labs.
  • Begin fiber diversity, fermented foods, circadian alignment, and stress downregulation.
  • Start gentle probiotics and mucosal support (glutamine, zinc carnosine) if permeability is suspected.

• Phase 2: Targeted correction

• • Address dysbiosis with antimicrobial botanicals or tailored probiotics; titrate prebiotics.
  • Support bile flow and enzymes; add butyrate donors.
  • Integrative chiropractic care focusing on autonomic balance, rib-cage/diaphragm mobility, and lumbosacral mechanics.

• Phase 3: Reconstruction

• • Expand prebiotic fibers and resistant starches; layer polyphenol-rich foods.
  • Calibrate macronutrients to metabolic goals; add omega-3s.
  • Maintain sleep and stress programs; individualized movement medicine.

• Phase 4: Maintenance and personalization

• • Reassess labs and symptoms; titrate supplements down as diet and lifestyle stabilize.
  • Ongoing neuromechanical care for posture, rib-cage mobility, and pelvic floor coordination.
  • Plan seasonal tune-ups after high-stress periods such as 2025-12-01 through 2025-12-31.

Clinical Case Insights and Observations

• Glycemic stability

• • When we correct dysbiosis and restore barrier integrity, postprandial crashes diminish, and glycemic variability decreases. y. I often reduce diabetes medications rather than escalate them, reflecting improved SCFA signaling and lower LPS burden (Cani et al., 2008).

• Thyroid and autoimmunity

• • With micronutrient optimization and a lower inflammatory tone, patients frequently required less levothyroxine and exhibited steadier TSH, free T4, and free T3 levels (Virili et al., 2019).

• Skin and mood

• • Acne and eczema flares recede; cognition clears and mood steadies within 4–8 weeks of gut-focused protocols paired with autonomic regulation.

• Pellets and free testosterone

• • I see recurring late-cycle dips in free T with pellets. Adding shilajit maintains higher free T and symptom stability without dose escalation, aligning with randomized trial data (Pandit et al., 2015).

Why Integrative Chiropractic Is a Linchpin

Manual care reduces nociceptive drive and sympathetic arousal, which otherwise perpetuate gut permeability and hormone dysregulation. Diaphragmatic and thoracic mobility massage the viscera, improve peristalsis and bile flow, and facilitate lymphatic return for metabolite clearance. When I pair chiropractic with targeted nutrition, methylation support, and microbiome therapy, patients transition from chronic alarm to steady recovery—documented repeatedly in my practice and shared at https://chiropracticscientist.com/ and https://www.linkedin.com/in/dralexjimenez/.

Frequently Asked Questions

• Why don’t diets and supplements always work?

• • If the barrier is compromised or bile flow is poor, fibers and nutrients can aggravate symptoms. Sequence matters: repair mucosa and motility before aggressive fiber loading.

• Can chiropractic alone fix the gut?

• • Chiropractic is a powerful autonomic and mechanical modulator, but the microbiome requires nutritional substrates and immune balance. Integration produces synergy.

• How fast does improvement occur?

• • Many patients notice digestive and mood changes within 2–4 weeks; deeper immune and hormonal recalibration often requires 8–16 weeks with sustained gains over months as diversity rebuilds.

References

• Short-chain fatty acids and intestinal homeostasis (Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F., 2016). Cell Host & Microbe, 20(2), 146–158. https://doi.org/10.1016/j.chom.2016.07.004
• Microbiota’s role in immune regulation (Belkaid, Y., & Hand, T. W., 2014). Nature Reviews Immunology, 14(10), 632–640. https://doi.org/10.1038/nri3640
• Bile acids and metabolic regulation (Jia, W., Xie, G., & Jia, W., 2018). Frontiers in Physiology, 9, 1853. https://doi.org/10.3389/fphys.2018.01853
• Metabolic endotoxemia and insulin resistance (Cani, P. D., Amar, J., et al., 2008). Diabetes, 57(6), 1470–1481. https://doi.org/10.2337/db07-1403
• Zonulin and gastrointestinal barrier function (Fasano, A., 2012). Gastroenterology, 142(6), 1393–1401.
• Mechanisms of increased intestinal permeability (Camilleri, M. et al., 2019). Gastroenterology, 156(6), 1644–1659.
• Tryptophan metabolism and the microbiome (Agus, A., Planchais, J., & Sokol, H., 2018). Cell Host & Microbe, 23(6), 716–724. https://doi.org/10.1016/j.chom.2018.05.009
• Circadian rhythms and intestinal physiology (Voigt, R. M., Forsyth, C. B., et al., 2014). Gastroenterology, 146(5), 1219–1233. https://doi.org/10.1053/j.gastro.2014.01.036
• Probiotics: consensus and guidelines (Hill, C., Guarner, F., et al., 2014). Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514. https://doi.org/10.1038/nrgastro.2014.66
• Diet diversity and microbiome health (Asnicar, F., Berry, S. E., et al., 2021). Nature Microbiology, 6, 1319–1329. https://doi.org/10.1038/s41564-021-00984-6
• Fermented foods increase diversity (Wastyk, H. C., Fragiadakis, G. K., et al., 2021). Cell, 184(16), 4137–4153.e14. https://doi.org/10.1016/j.cell.2021.07.019
• DIM and 2-hydroxyestrone favoring (Bradlow, H. L., Telang, N. T., Sepkovic, D. W., & Osborne, M. P., 1998). Journal of Endocrinology, 152, 123–129.
• Indoles and AhR modulation (Safe, S. et al., 2013). Biochemical Pharmacology, 86(6), 929–938.
• DIM in apoptosis and cell-cycle arrest (Li, Y., t al., 2013). Life Sciences, 92(10), 744–757.
• Nrf2 activation by sulforaphane (Clarke, J. D., et al., 2011). Free Radical Biology and Medicine, 51(2), 193–200.
• NF-?B and chronic oxidative stress (Pall, M. L., & Levine, S., 2015). Redox Biology, 6, 1–7.
• Sulforaphane and breast chemoprevention (Zhang, Y. et al., 2016). Food and Chemical Toxicology, 98, 1–10.
• Estrogen quinones and cancer risk (Cavalieri, E., & Rogan, E., 2011). Endocrine-Related Cancer, 18(6), R1–R14.
• Estrogen metabolism pathways (Zuberi, M. et al., 2021). Scientific Reports, 11, 7453.
• COMT pharmacogenetics (Weinshilboum, R. M., & Sladek, S. L., 1980). PNAS, 77(5), 2871–2875.
• Estrogen glucuronidation and cycling (Goldin, B. R., & Gorbach, S. L., 1984). American Journal of Clinical Nutrition, 40(4), 499–508.
• Microbiome and estrogen deconjugation (Sui, Y., et al., 2021). Frontiers in Endocrinology, 12, 607–613.
• Vitamin D deficiency prevalence (van Schoor, N. M., & Lips, P., 2017). Endocrinology and Metabolism Clinics.
• Vitamin D and mortality (Scragg, R., 2018). Current Opinion in Clinical Nutrition and Metabolic Care.
• Vitamin D and human health (Heath, A. K., et al., 2019). Clinical Endocrinology.
• Magnesium for vitamin D metabolism (Deng, X., t al., 2013). The Journal of the American Osteopathic Association.
• MK-7 and extrahepatic K-dependent processes (Knapen, M. H. J., et al., 2015). The Journal of Nutrition.
• Vitamin K2, osteocalcin, and MGP (Schurgers, L. J., et al., 2008). Thrombosis and Hemostasis.
• Vitamin A in bone and immunity (McCollum, E. V., et al., 2016). Nutrients.
• Selenium in thyroid health (Kohrle, J., 2005). Biochimie.
• Gut–thyroid axis and autoimmunity (Virili, C. et al., 2019). Endocrine Reviews.
• Selenium supplementation in autoimmunity (Winther, K. H., et al., 2020). Thyroid Research.
• Omega-3s and inflammation (Calder, P. C., 2017). Biomedicine & Pharmacotherapy, 86, 123–133.
• CoQ10 bioenergetics (Littarru, G. P., & Tiano, L., 2007). Mitochondrion, 7(Suppl), S168–S174.
• CoQ10 clinical applications (Saini, R., 2011). Nutrition, 27(2), 250–254.
• Fenugreek applications (Basch, E., t al., 2003). Pharmacology.
• Fenugreek and male vitality (Steels, E., e al., 2011). Nutrition Journal, 10, 54.
• Purified shilajit increases testosterone (Pandit, S., etal, 2015). Journal of Pharmacy and Pharmacology, 67(8).
• Shilajit is an adaptogen (Corso, C. R., et al., 2017). Phytotherapy Research, 31(7), 1023–1029.
• Vagus nerve and inflammatory control (Breit, S. et al., 2018). Frontiers in Psychiatry.
• Polyvagal theory (Porges, S. W., 2011). Clinical applications in psychophysiology.

SEO tags: gut health, microbiome, dysbiosis, integrative chiropractic, functional medicine, immune system, hormones, estrogen metabolism, thyroid function, insulin resistance, cortisol, SCFA, butyrate, leaky gut, vagal tone, bile acids, SIBO, fermented foods, probiotics, prebiotics, berberine, circadian rhythm, stress management, diaphragm mobility, pelvic floor, HHashimoto’s mood and gut, seasonal depression, GLP-1, evidence-based care, vitamin D, vitamin K2, magnesium, iodine, selenium, DIM, sulforaphane, shilajit, free testosterone, HRT support, Akkermansia muciniphila